Healthcare Jan 06, 2022 09:26 AM (GMT+8) · EqualOcean
On January 6, Jiayue pharmaceutical announced that it had completed nearly 200 million yuan of B + round financing, which was led by Guanzi venture capital, and the old shareholder Guotou venture capital, Sequoia Capital China fund and Lingcheng venture capital continued to follow. This is a new round of financing completed by Jiayue pharmaceutical within half a year after the completion of round B financing in July 2021. This round of financing will be used to promote the middle and later clinical projects of many innovative drug pipeline lines of the company.